Home » Topics » Regulatory

Regulatory
RSS

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Crixivan pediatric formulation in development

May 24, 1996

Amlexanox approvable in U.S.

May 24, 1996

Propecia NDA filing slated for late 1996

May 24, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

FK-409 claimed as portal hypertension Rx

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

Seven new uses for raloxifene appear in patent literature

May 17, 1996

Valproate effective in dementia patients

May 17, 1996

Ketoconazole: Potential treatment for depression?

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...